Back To Top
Celltrion says new antibody treatment effective in tests with mutated type of new coronavirus
Celltrion says new antibody treatment effective in tests with mutated type of new coronavirus
IndustryJul 8, 2020
Celltrion, a leading pharmaceutical firm in South Korea, said on Wednesday that its new antibody treatment showed some promise in treating a mutated version of the new coronavirus in recent tests.     The company said the new drug successfully neutralized the "G614" type of the virus. It was 10 times more effective in treating the G614 type than the original virus, the company said.      The test was conducted last month by the state-run Korea Cent